Bioceptive, Inc. — Form D/A

Bioceptive, Inc. of NEW ORLEANS, LA, a company, filed a Form D amendment with the SEC on 2012-03-26. The offering totals $250K, of which $40K was reported sold. Industry: Other.

Offering

Filed: 2012-03-26
Form: D/A
Accession: 0001527900-12-000002
Industry: Other
Exemptions: 06
Total offering: $250K
Amount sold: $40K
Remaining: $210K
Investors: 2
Date of first sale: 2012-03-12
Security types: equity
Revenue range: No Revenues
SEC file number: 021-175537

Issuer

Name: Bioceptive, Inc.
CIK: 0001527900
Entity type: Corporation
Jurisdiction: DELAWARE
Incorporated: 2011
Address: NEW ORLEANS BIOINNOVATION CENTER, NEW ORLEANS, LA, 70112
Phone: (504) 598-5233

Officers, directors & promoters (12)

Name	Role	Location
John Hardman	Director	Atlanta, GA
Benjamin Cappiello	Director	New Orleans, LA
Benjamin Cappiello	Executive Officer	New Orleans, LA
TOM BALDERSTON	Director	Atlanta, GA
Joan Neuscheler	Director	New Orleans, LA
Joseph Kumar Lovett	Director	Baton Rouge, LA
Amit Kumar Rathi	Director	Bangalore, K7
Orin Levy	Director	Boca Raton, FL
Shuchi Kumar Khurana	Executive Officer	New Orleans, LA
Shuchi Khurana	Executive Officer	New Orleans, LA
Stewart Davis	Director	New Orleans, LA
Stewart Davis	Executive Officer	New Orleans, LA

Other filings by this issuer (6)

Filed	Form	Offering	Sold
2016-01-29	D	$650K	$416K
2013-12-30	D	$1.5M	$1.3M
2013-03-01	D/A	$1.1M	$1.1M
2012-10-24	D	$1.0M	—
2012-03-26	D	$200K	$40K
2011-08-15	D	$135K	$135K

More